Azasite

DRUG5 trials

Sponsors

Merck Sharp & Dohme LLC, Alcon Research, Sun Pharmaceutical Industries Limited, Philadelphia Eye Associates

Conditions

Bacterial ConjunctivitisBlepharitisMeibomian Gland Dysfunction

Phase 2

Study to Determine the Effect of Azasite on Corneal Surface Irregularity

WithdrawnNCT01797107

Philadelphia Eye AssociatesMeibomian Gland Dysfunction

Start: 2013-03-31End: 2014-07-31Updated: 2016-09-28

Phase 3

Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)

CompletedNCT00105469

Merck Sharp & Dohme LLCBacterial Conjunctivitis

Start: 2004-07-31End: 2005-10-31Updated: 2013-12-16

Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)

CompletedNCT00105534

Merck Sharp & Dohme LLCBacterial Conjunctivitis

Start: 2004-07-31End: 2006-01-31Updated: 2013-11-21

A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis

CompletedNCT01102244

Alcon ResearchBlepharitis

Start: 2010-04-30Updated: 2012-06-11

Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis

CompletedNCT01408082

Sun Pharmaceutical Industries LimitedBlepharitis

Start: 2011-10-31End: 2013-06-30Updated: 2021-11-19

Related Papers

Development and evaluation of a measure of patient-reported symptoms of Blepharitis.

2018-01-1125 citations

Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.

2010-12-0729 citations

Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis.

2007-08-0135 citations